118 related articles for article (PubMed ID: 35638529)
1. Effects of Oncogene Neuregulin 1 on Breast Cancer Cells.
Li Q; Zhu B; Chen J; Wang H; Wu Y; Chen H; He X
Pak J Biol Sci; 2022 Jan; 25(4):345-352. PubMed ID: 35638529
[TBL] [Abstract][Full Text] [Related]
2. [Neuregulin-1 promotes proliferation and migration of human coronary artery smooth muscle cells by enhancing its receptor phosphorylation].
He F; Gui C; Li L; Chen L; Qi B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1643-6. PubMed ID: 26648299
[TBL] [Abstract][Full Text] [Related]
3. Apoptotic Activity and Cytotoxic Effect of
Ahmed Mobasher M
Pak J Biol Sci; 2021 Jan; 24(6):646-655. PubMed ID: 34486340
[TBL] [Abstract][Full Text] [Related]
4. A novel neuregulin - jagged1 paracrine loop in breast cancer transendothelial migration.
Cabrera RM; Mao SPH; Surve CR; Condeelis JS; Segall JE
Breast Cancer Res; 2018 Apr; 20(1):24. PubMed ID: 29636067
[TBL] [Abstract][Full Text] [Related]
5. Neuregulin-1 induces cancer stem cell characteristics in breast cancer cell lines.
Jeong H; Kim J; Lee Y; Seo JH; Hong SR; Kim A
Oncol Rep; 2014 Sep; 32(3):1218-24. PubMed ID: 25018110
[TBL] [Abstract][Full Text] [Related]
6. NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells.
Yang L; Li Y; Shen E; Cao F; Li L; Li X; Wang X; Kariminia S; Chang B; Li H; Li Q
Int J Oncol; 2017 Nov; 51(5):1553-1562. PubMed ID: 29048656
[TBL] [Abstract][Full Text] [Related]
7. NRG1 fusions in breast cancer.
Howarth KD; Mirza T; Cooke SL; Chin SF; Pole JC; Turro E; Eldridge MD; Garcia RM; Rueda OM; Boursnell C; Abraham JE; Caldas C; Edwards PAW
Breast Cancer Res; 2021 Jan; 23(1):3. PubMed ID: 33413557
[TBL] [Abstract][Full Text] [Related]
8. miR‑589‑3p sponged by the lncRNA TINCR inhibits the proliferation, migration and invasion and promotes the apoptosis of breast cancer cells by suppressing the Akt pathway via IGF1R.
Guo F; Zhu X; Zhao Q; Huang Q
Int J Mol Med; 2020 Sep; 46(3):989-1002. PubMed ID: 32705168
[TBL] [Abstract][Full Text] [Related]
9. The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene.
Chua YL; Ito Y; Pole JC; Newman S; Chin SF; Stein RC; Ellis IO; Caldas C; O'Hare MJ; Murrell A; Edwards PA
Oncogene; 2009 Nov; 28(46):4041-52. PubMed ID: 19802002
[TBL] [Abstract][Full Text] [Related]
10. Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.
Haskins JW; Nguyen DX; Stern DF
Sci Signal; 2014 Dec; 7(355):ra116. PubMed ID: 25492965
[TBL] [Abstract][Full Text] [Related]
11. Safflower (
Fristiohady A; Al-Ramadan W; Fitrawan OM; Hamsidi R; Purnama OMJ; Malaka MH; Haruna LA; Sahidin
Pak J Biol Sci; 2023 Jul; 26(8):427-433. PubMed ID: 37937336
[TBL] [Abstract][Full Text] [Related]
12. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
13. MiR-125a-3p regulates glioma apoptosis and invasion by regulating Nrg1.
Yin F; Zhang JN; Wang SW; Zhou CH; Zhao MM; Fan WH; Fan M; Liu S
PLoS One; 2015; 10(1):e0116759. PubMed ID: 25560389
[TBL] [Abstract][Full Text] [Related]
14. Targeting Neuregulin 1 (NRG1): A Novel Biomarker for Non-Small-Cell Lung Cancer.
Fang C; Kang B; Zhao P; Ran J; Wang L; Zhao L; Luo H; Tao L
J Environ Pathol Toxicol Oncol; 2021; 40(4):61-72. PubMed ID: 34936301
[TBL] [Abstract][Full Text] [Related]
15. Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction.
Liang X; Ding Y; Zhang Y; Chai YH; He J; Chiu SM; Gao F; Tse HF; Lian Q
Cell Death Dis; 2015 May; 6(5):e1765. PubMed ID: 25996292
[TBL] [Abstract][Full Text] [Related]
16. A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.
Adélaïde J; Huang HE; Murati A; Alsop AE; Orsetti B; Mozziconacci MJ; Popovici C; Ginestier C; Letessier A; Basset C; Courtay-Cahen C; Jacquemier J; Theillet C; Birnbaum D; Edwards PA; Chaffanet M
Genes Chromosomes Cancer; 2003 Aug; 37(4):333-45. PubMed ID: 12800145
[TBL] [Abstract][Full Text] [Related]
17. The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic
Odintsov I; Lui AJW; Sisso WJ; Gladstone E; Liu Z; Delasos L; Kurth RI; Sisso EM; Vojnic M; Khodos I; Mattar MS; de Stanchina E; Leland SM; Ladanyi M; Somwar R
Clin Cancer Res; 2021 Jun; 27(11):3154-3166. PubMed ID: 33824166
[TBL] [Abstract][Full Text] [Related]
18. Neuregulin 1/ErbB4/Akt signaling attenuates cytotoxicity mediated by the APP-CT31 fragment of amyloid precursor protein.
Yoo JY; Kim HB; Baik TK; Lee JH; Woo RS
Exp Mol Pathol; 2021 Jun; 120():104622. PubMed ID: 33684392
[TBL] [Abstract][Full Text] [Related]
19. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer.
Ogier C; Colombo PE; Bousquet C; Canterel-Thouennon L; Sicard P; Garambois V; Thomas G; Gaborit N; Jarlier M; Pirot N; Pugnière M; Vie N; Gongora C; Martineau P; Robert B; Pèlegrin A; Chardès T; Larbouret C
Cancer Lett; 2018 Sep; 432():227-236. PubMed ID: 29935372
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic Fusion Gene CD74-NRG1 Confers Cancer Stem Cell-like Properties in Lung Cancer through a IGF2 Autocrine/Paracrine Circuit.
Murayama T; Nakaoku T; Enari M; Nishimura T; Tominaga K; Nakata A; Tojo A; Sugano S; Kohno T; Gotoh N
Cancer Res; 2016 Feb; 76(4):974-83. PubMed ID: 26837769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]